1. Alzheimer's disease assessment scale‐cognitive 11‐item progression model in mild‐to‐moderate Alzheimer's disease trials of bapineuzumab. Issue 3 (5th October 2015) Authors: Samtani, Mahesh N.; Xu, Steven X.; Russu, Alberto; Adedokun, Omoniyi J.; Lu, Ming; Ito, Kaori; Corrigan, Brian; Raje, Sangeeta; Brashear, H. Robert; Styren, Scot; Hu, Chuanpu Journal: Alzheimer's & dementia Issue: Volume 1:Issue 3(2015) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials. Issue 2 (21st July 2015) Authors: Xu, Steven X.; Samtani, Mahesh N.; Russu, Alberto; Adedokun, Omoniyi J.; Lu, Ming; Ito, Kaori; Corrigan, Brian; Raje, Sangeeta; Brashear, H. Robert; Styren, Scot; Hu, Chuanpu Journal: Alzheimer's & dementia Issue: Volume 1:Issue 2(2015) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IC‐P‐015: Evaluation of the pons as a reference region for amyloid PET in Alzheimer's disease clinical trials. (1st July 2013) Authors: Margolin, Richard; Schmidt, Mark; Gregg, Keith; Les, Andrea; Hill, Derek; Koeppe, Robert; Wyman, Bradley; Styren, Scot; Grundman, Michael; Yuen, Eric; Brashear, Robert H.; Liu, Enchi Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 1 Page Start: P18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-term safety and tolerability of bapineuzumab in patients with Alzheimer's disease in two phase 3 extension studies. Issue 1 (December 2016) Authors: Ivanoiu, Adrian; Pariente, Jérémie; Booth, Kevin; Lobello, Kasia; Luscan, Gerald; Hua, Lisa; Lucas, Prisca; Styren, Scot; Yang, Lingfeng; Li, David; Black, Ronald; Brashear, H.; McRae, Thomas Journal: Alzheimer's research & therapy Issue: Volume 8:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Multiple‐dose ponezumab for mild‐to‐moderate Alzheimer's disease: Safety and efficacy. Issue 3 (10th May 2017) Authors: Landen, Jaren W.; Cohen, Sharon; Billing, Clare B.; Cronenberger, Carol; Styren, Scot; Burstein, Aaron H.; Sattler, Catherine; Lee, Jae‐Hong; Jack, Clifford R.; Kantarci, Kejal; Schwartz, Pamela F.; Duggan, William T.; Zhao, Qinying; Sprenger, Ken; Bednar, Martin M.; Binneman, Brendon Journal: Alzheimer's & dementia Issue: Volume 3:Issue 3(2017) Page Start: 339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. O1–06–02: Effect of bapineuzumab on CSF p‐tau and t‐tau in mild‐to‐moderate Alzheimer's disease: Results from two phase III trials in APOE‐ε4 carriers and noncarriers. (1st July 2013) Authors: Streffer, Johannes; Blennow, Kaj; Salloway, Stephen; Zetterberg, Henrik; Xu, Yi‐Zheng; Lu, Yuan; Lull, Julia; Collins, Peter; Tudor, Iulia Cristina; Gregg, Keith; Styren, Scot; Yuen, Eric; Grundman, Michael; Brashear, Robert H.; Liu, Enchi Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 3 Page Start: P138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P1‐145: A PROSPECTIVE, SYSTEMATIC LITERATURE REVIEW AND META‐ANALYSES TO EVALUATE CEREBROSPINAL FLUID (CSF) PHOSPHORYLATED TAU (P‐TAU) AND TOTAL TAU (T‐TAU) AS BIOMARKERS OF ALZHEIMER'S DISEASE PROGRESSION. (1st July 2014) Authors: Liu, Enchi; Ashaye, Ajibade O.; Travers, Karin; Strand, Lauren; Olsson, Kelly; Tanna, Gian Luca; Booth, Kevin; Styren, Scot; Brashear, H. Robert; Streffer, Johannes Rolf; Liu, Enchi Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 9 Page Start: P353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P1‐146: A PROSPECTIVE, SYSTEMATIC LITERATURE REVIEW AND META‐ANALYSES TO EVALUATE BRAIN AMYLOID BY POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AS A BIOMARKER OF ALZHEIMER'S DISEASE (AD) PROGRESSION. (1st July 2014) Authors: Liu, Enchi; Ashaye, Ajibade; Travers, Karin; Strand, Lauren; Tanna, Gian Luca; Wyman, Bradley T.; Booth, Kevin; Styren, Scot; Brashear, Robert; Margolin, Richard; Schmidt, Mark Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 9 Page Start: P353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P1‐147: A PROSPECTIVE, SYSTEMATIC LITERATURE REVIEW AND META‐ANALYSES TO EVALUATE GLOBAL AND REGIONAL BRAIN VOLUMES BY STRUCTURAL MRI AS BIOMARKERS OF ALZHEIMER'S DISEASE (AD) PROGRESSION. (1st July 2014) Authors: Liu, Enchi; Ashaye, Ajibade; Travers, Karin; Strand, Lauren; Olsson, Kelly; Tanna, Gian Luca; Wyman, Bradley T.; Booth, Kevin; Styren, Scot; Brashear, Robert H.; Einstein, Steven; Novak, Gerald Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 9 Page Start: P354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P1–346: Disease progression modeling of bapineuzumab utilizing Alzheimer's Disability Assessment for Dementia scores. (1st July 2013) Authors: Samtani, Mahesh; Xu, Steven; Adedokun, O.J.; Ito, Kaori; Corrigan, Brian; Raje, Sangeeta; Brashear, Robert H.; Styren, Scot; Hu, Chuanpu; Lu, Ming Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 7 Page Start: P284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗